Digital mental health subscription service Cerebral raises $35M Series A led by Oak HC/FT
Laura Lovett / MobiHealthNews :
Context & Ripple Effects
This $35M Series A from Oak HC/FT is the starting gun of one of digital health's fastest valuation climbs: within eight months Cerebral raised a $127M round at a $1.23B valuation, and by December 2021 a $300M round led by SoftBank Vision Fund 2 put it at $4.8B — roughly a hundredfold markup on this round's price in about fourteen months.
What the capital bought was later scrutinized: reporting on the quota-contingent staff health insurance surfaced weeks after that December round, and the company's prescribing-led growth — including its ADHD medication business — became the focus of FTC enforcement over data sharing and cancellation practices.
First-order effects
- Oak HC/FT's check funds Cerebral's app-based bundle of counseling and medication, putting a subscription-prescribing hybrid into direct competition with employer-channel rival Modern Health, which had just cleared $95M in total funding.
Second-order effects
- The round helps set the pace for a sector-wide funding wave: SoftBank Vision Fund 2 backs both Cerebral and Big Health's $75M Series C, while Iris Telehealth raises its own $40M Series B for virtual mental health care.
Third-order effects
- If the pattern holds, the prescribing-heavy growth model that made Cerebral's valuation surge will draw regulators into defining quality-of-care and data-privacy standards for app-based mental health, reshaping how the whole category can acquire and treat patients.
The trend: Virtual-first mental health startups scaled on medication-driven subscriptions faster than oversight could follow, making the sector's reckoning with privacy and care quality the next chapter.